ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 134 filers reported holding ACLARIS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $341,782 | -24.6% | 49,895 | +14.1% | 0.00% | – |
| Q2 2023 | $453,574 | +166.4% | 43,739 | +107.8% | 0.00% | – |
| Q1 2023 | $170,278 | -46.2% | 21,048 | +4.7% | 0.00% | – |
| Q4 2022 | $316,717 | +2.8% | 20,109 | +2.5% | 0.00% | – |
| Q3 2022 | $308,000 | +24.7% | 19,624 | +10.9% | 0.00% | – |
| Q2 2022 | $247,000 | -13.6% | 17,689 | +6.6% | 0.00% | – |
| Q1 2022 | $286,000 | +24.9% | 16,601 | +5.6% | 0.00% | – |
| Q4 2021 | $229,000 | -18.5% | 15,725 | +0.7% | 0.00% | – |
| Q3 2021 | $281,000 | +157.8% | 15,618 | +153.0% | 0.00% | – |
| Q2 2021 | $109,000 | +1716.7% | 6,172 | +11.8% | 0.00% | – |
| Q1 2020 | $6,000 | -40.0% | 5,519 | 0.0% | 0.00% | – |
| Q4 2019 | $10,000 | +66.7% | 5,519 | 0.0% | 0.00% | – |
| Q3 2019 | $6,000 | -50.0% | 5,519 | 0.0% | 0.00% | – |
| Q2 2019 | $12,000 | -69.2% | 5,519 | -15.0% | 0.00% | – |
| Q1 2019 | $39,000 | -18.8% | 6,495 | 0.0% | 0.00% | – |
| Q4 2018 | $48,000 | -15.8% | 6,495 | +64.1% | 0.00% | – |
| Q3 2018 | $57,000 | -27.8% | 3,959 | 0.0% | 0.00% | – |
| Q2 2018 | $79,000 | +12.9% | 3,959 | -0.7% | 0.00% | – |
| Q1 2018 | $70,000 | -48.5% | 3,986 | -27.4% | 0.00% | – |
| Q4 2017 | $136,000 | -6.8% | 5,491 | -3.2% | 0.00% | – |
| Q3 2017 | $146,000 | +2.8% | 5,672 | +8.0% | 0.00% | – |
| Q2 2017 | $142,000 | +79.7% | 5,254 | +98.3% | 0.00% | – |
| Q1 2017 | $79,000 | +5.3% | 2,649 | -3.8% | 0.00% | – |
| Q4 2016 | $75,000 | +78.6% | 2,753 | +68.1% | 0.00% | – |
| Q3 2016 | $42,000 | +35.5% | 1,638 | 0.0% | 0.00% | – |
| Q2 2016 | $31,000 | – | 1,638 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |